hotspot -WSS

hotspot

author：focus 2025-08-12 09:10:44 - browse：7346

Pfizer is this year’s anti-Eli Lilly. If David Ricks is the best biopharma CEO of 2023, then Pfizer CEO Albert Bourlais, unfortunately, the worst.

My annual Worst Biopharma CEO list is typically populated with blockheads and scoundrels. That’s not why Bourla is here. The reason is accountability. Strategic missteps, financial miscalculations, and scientific setbacks have plunged Pfizer into a deep crisis. Bourla is the man at the top, so the responsibility lies with him.

Pfizer shares have fallen 50% this year to their lowest level in more than a decade, erasing nearly $140 billion in market value. In 2022, the company delivered $100 billion in revenue, boosted by a widely used Covid vaccine and Covid treatment. This year, Covid product sales evaporated — and will fall further next year — leaving a vacuum Pfizer is struggling to fill with aging medicines nearing the end of their patent lives, and newer drugs and vaccines that have not performed as expected.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Duchenne breakthrough therapy leaves behind pioneering families

WSS

FDA does about

Activists slam private health insurers over coverage restrictions

How to address the problem of discarded donor organs

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

ChatGPT in medicine: STAT answers readers' burning questions

House looks to weaken Medicare negotiation

hotspot

hotspot

entertainment

Guidelines to prevent youth baseball injuries need more muscle

Anesthesiologist group: stop taking Ozempic before surgery

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Alkermes shareholders re

Congress gives doctors Medicare pay bump

Dobbs anniversary: the lost opportunity of abortion as health care

Kenai launches with $82 million for Parkinson’s stem cell therapy

Duchenne breakthrough therapy leaves behind pioneering families

RSV vaccines may be linked to small increased risk of developing GBS

hotspot

In age of alternative facts, a scholarly course on calling out crap

The cancer drug shortage isn’t new — and neither are the solutions

House looks to weaken Medicare negotiation

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

leisure time

hotspot

entertainment

entertainment